CHRN ChronoScale Corp.

  1. Stocks
  2. Technology
  3. NASDAQ: CHRN

Price (delayed)

$20.01

Market cap

$2.91B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.36

Enterprise value

$3.03B

?
Relative Growth: Rel. Growth: 24
Relative Strength: Rel. Strength: 98
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 19

® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, ...

Highlights
ChronoScale's equity has surged by 136% YoY
CHRN's EPS has surged by 93% since the previous quarter and by 32% year-on-year
CHRN's gross margin has shrunk by 145% QoQ but it is up by 35% YoY
CHRN's quick ratio has shrunk by 72% QoQ
ChronoScale's revenue has decreased by 15% YoY
Sector: Technology
Industry: Information Technology Services
Website: https://chronoscale.com
Peers: STAA IART TNDM

Key stats

What are the main financial stats of CHRN

CHRN stock price

How has the ChronoScale stock price performed over time
Intraday
3.3%
1 week
0.81%
1 month
5.26%
1 year
276.13%
YTD
131.6%
QTD
1.42%

Financial performance

How have ChronoScale's revenue and profit performed over time
Revenue
$71.6M
Gross profit
-$17.09M
Operating income
-$37.5M
Net income
-$50.32M
Gross margin
-23.9%
Net margin
-70.3%
CHRN's gross margin has shrunk by 145% QoQ but it is up by 35% YoY
CHRN's operating income has dropped by 142% since the previous quarter but it is up by 32% year-on-year
CHRN's operating margin has soared by 61% QoQ and by 20% YoY
The net margin is up by 48% QoQ and by 18% YoY

Price vs fundamentals

How does CHRN's price correlate with its fundamentals

Growth

What is ChronoScale's growth rate over time

Valuation

What is ChronoScale stock price valuation
P/E
N/A
P/B
0.4
P/S
38.76
EV/EBIT
N/A
EV/EBITDA
74.44
EV/Sales
42.25
CHRN's EPS has surged by 93% since the previous quarter and by 32% year-on-year
ChronoScale's equity has surged by 136% YoY
CHRN's P/B is 93% below its last 4 quarters average of 5.6 and 81% below its 5-year quarterly average of 2.0
ChronoScale's revenue has decreased by 15% YoY

Efficiency

How efficient is ChronoScale business performance
The ROIC has soared by 92% from the previous quarter and by 18% YoY
The ROE has soared by 81% from the previous quarter and by 59% YoY
The ROA has soared by 76% from the previous quarter and by 33% YoY
CHRN's return on sales has surged by 57% since the previous quarter and by 13% year-on-year

Dividends

What is CHRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CHRN.

Financial health

How did ChronoScale financials performed over time
ChronoScale's total assets is 127% more than its total liabilities
CHRN's quick ratio has shrunk by 72% QoQ
The current ratio has dropped by 67% since the previous quarter
The debt is 33% lower than the equity
ChronoScale's equity has surged by 136% YoY
The debt to equity has dropped by 77% year-on-year and by 68% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.